Two or Three CRO Deals Could Take Some Pain Out of Pfizer Inc.'s Sandwich Exit

Pharma Times -- The UK government is putting its hopes on Pfizer’s efforts to attract contract research organisations to its abandoned R&D site at Sandwich as the solution to preserving jobs and activity there.